Priority evaluations

A request for registration of a multisource generic medication to the List of Medications for the basic prescription drug insurance plan or the List of Medications – Institutions may be processed in priority for economic reasons.   

Economic motive

Pursuant to the Pharmaceutical Policy, a multisource generic medication may be subject to a priority evaluation if its registration is conducive to bringing significant savings to the public health care system.   

The potential savings threshold for a medication to be prioritised for economic reasons is established annually. For 2021, this threshold was set at $200,000 per month for anticipated registrations. 

The deadlines for the receipt of requests for priority evaluation of multisource generic drug products for economic reasons are:

 

Next updateDeadline for receipt of requests for priority evaluation (generics drugs)
February 3, 2021November 25, 2020
March 3, 2021January 6, 2021
April 14, 2021February 17, 2021
May 27, 2021March 31, 2021
July 7, 2021May 12, 2021
August 18, 2021June 23, 2021
September 29, 2021August, 4 2021
November 10, 2021September 15, 2021
December 15, 2021October 20, 2021

Subscribe to our newsletter now

Subscription